Abstract
The hepatitis B virus (HBV) is a major global issue, because an increased risk of hepatocellular carcinoma among patients infected with HBV is well established. Recently, it has been suggested that HBV is associated with other human cancers. However, the association between HBV and the risk of onset of hematological malignancies remains controversial. The aim of this large-scale retrospective cohort study was to evaluate the association between HBV infection and hematological malignancies. A retrospective analysis of 86,115 newly admitted patients at Shanghai Ruijin Hospital was performed. A cohort of patients previously exposed to HBV (n = 1,874) and a cohort of individuals without a positive test for anti-hepatitis B core antigen (anti-HBc; n = 45,118) were compared to assess the risk of hematological malignancies. Anti-HBc was positive in 61.2% cases and 54.3% controls (p = 0.0001). The risk of B cell non-Hodgkin's lymphoma, acute lymphoblastic leukemia, and multiple myeloma was higher in the HBV-infected cohort than in the non-HBV-infected cohort. In conclusion, patients infected with HBV have a substantially increased risk of hematological malignancies.
References
Apr 1, 1987·Journal of Hepatology·C Bréchot
Dec 11, 1997·The New England Journal of Medicine·W M Lee
Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J P BronowickiC Bréchot
Aug 14, 1999·Journal of Medical Virology·R FukudaY Kinoshita
Oct 4, 2002·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Santiago J Muñoz
Jul 12, 2003·The Journal of Biological Chemistry·Young-Gun YooMi-Ock Lee
Jan 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S F Lok, Brian J McMahon
Oct 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manal M HassanJames L Abbruzzese
Oct 30, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lesley A AndersonEric A Engels
Apr 8, 2009·The Lancet Oncology·Véronique BouvardUNKNOWN WHO International Agency for Research on Cancer Monograph Working Group
Sep 5, 2009·Vaccine·Xiaofeng LiangYu Wang
Jan 7, 2010·Nature Reviews. Gastroenterology & Hepatology·Heiner Wedemeyer, Michael P Manns
Jan 26, 2010·Scandinavian Journal of Gastroenterology·Kenichi ItoOsamu Yokosuka
Sep 8, 2010·Annals of Hematology·Jun KangJooryung Huh
Nov 26, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Silvia FranceschiPaolo Vineis
Jun 22, 2011·Clinics in Liver Disease·Romy ZemelRan Tur-Kaspa
Jul 15, 2011·Reviews in Medical Virology·Samuel Martin-VilchezPaloma Sanz-Cameno
May 12, 2012·The Lancet Oncology·Catherine de MartelMartyn Plummer
Jan 29, 2014·Medical Oncology·Zheng WeiYunfeng Cheng
Oct 8, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wai-Kay SetoMan-Fung Yuen
Oct 21, 2014·PloS One·Qian QiuZhong-ping Duan
Dec 17, 2014·JAMA : the Journal of the American Medical Association·He HuangTongyu Lin
Dec 23, 2014·PloS One·Baolin LiaoWeiping Cai
Feb 5, 2015·Journal of Viral Hepatitis·E S AndersenUNKNOWN DANVIR Cohort Study
May 9, 2015·World Journal of Hepatology·Venessa Pattullo